Summary
- New rules issued by the National Medical Products Administration aim to encourage the local production of certain pharmaceutical products
- Chinese applicants are specifically targeted by the rules
- Priority review
New Rules on Local Production of Imported Drugs in China
Fang Jianwei, Lv Chao and Yuan Chenhao of Zhong Lun Law Firm in Shanghai explain the background and impact – including on multinational companies – of a set of new rules governing the local production of imported drugs
By
Susan Mok